Clinical trial
An Observational Study for Analysis of Mortality in Participants Who…
NCT00297414 · Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry · Completed
Key facts
| NCT number | NCT00297414 |
|---|---|
| Title | An Observational Study for Analysis of Mortality in Participants Who Participated in Previous 3 Studies of Galantamine |
| Official title | An Analysis of Mortality in Subjects Who Participated in Three Studies of Galantamine in Mild Cognitive Impairment |
| Lead sponsor | Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Mild Cognitive Impairment |
| Intervention type | Other |
| Interventions | No intervention |
| Enrollment | 1,083 |
| Start date | Jun 1, 2004 |
| Primary completion | Jan 1, 2005 |
| Completion | Jan 1, 2005 |
| First posted | Feb 28, 2006 |
| Last update posted | Apr 12, 2012 |
| Countries | Argentina, Australia, Austria, Belgium, Canada, Czechia, Finland, France, Germany, Israel, Netherlands, Poland and 4 more |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: